Furthermore, KCNQ1OT1 has been demonstrated to promote chemoresistance of oxaliplatin by iR-34a/ATG4B pathway and it is associated with poor prognosis in COAD [43]. This evidence concerns the gene ATG4B and colon adenocarcinoma.